spacer
home > ict > Summer 2007
PUBLICATIONS

International Clinical Trials

ict
Summer 2007
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. ICT provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of ICT
   
Text
PDF
bullet
Regulatory & Business Practice
Study sites are regularly blamed by the industry for their incomplete knowledge of legal and regulatory requirements, whilst sponsors are accused of using tricky and difficult-to-understand legal jargon. In Building Consensus, Henry Yau at the Clinical Trials Centre proposes clinical trial agreements as a holistic solution to industry conflict  
view
download pdf
bullet
Clinical Trial Management
The heavy economic burden on health resources caused by adverse drug reactions means that the importance of drug safety cannot be overstated. In Not Just a Phase, Stuart Mair at Charles River Laboratories Clinical Services says the proof is in the planning and design during early drug development  
view
download pdf
In Image Conscious, Gunter Bellaire of Perceptive Informatics reflects on the features of a centralised imaging review in multicentre trials – a process driving forward the standardisation of image acquisition and independence from clinical patient information – that supports the objectivity of image analysis  
view
download pdf
Get research right, and not only will it allow you to designate recruitment tactics customised to the specific needs of each country, but it will also inform the cultural adaptation of the recruitment message. BBK Worldwide’s Elizabeth Gargill gets us Ready to Recruit  
view
download pdf
Since the mid-1990s, clinical research has expanded rapidly in Central and Eastern Europe. In Going Further East in CEE, Anna Anokhina and Dmitry Meshkov of MQ Quest Inc investigate the status of clinical studies in CEE and assess the mechanisms supporting further development of clinical trials  
view
download pdf
Faced with a drug development process running over budget and delivering too few approved novel compounds, Tom Parke of Tessella calls for adaptive clinical trials to radically overhaul the whole clinical trial sector, in Value Added Trials  
view
download pdf
bullet
eCLINICAL
Making time and quality improvements, whilst maintaining the integrity of the overall process, are enduring goals for clinical research teams. In an attempt to break the mould, Hui Li and Eva Miller of ALMAC Clinical Technologies discover new ways to leverage resources, in Clinical Teams and Tools  
view
download pdf
Technology is already playing a pivotal role in facilitating and speeding up both internal and external communication processes. Multi-site and multicountry pharmaceutical organisations are turning to truly global virtual teams to keep up with the pressure to modernise, explains Michael McGrath and Tom O’Leary of ICON, in The Driving Force of Technology  
view
download pdf
In the past decade CDISC has been developing and establishing standards that facilitate the collection, exchange, reporting and submission of clinical data, whilst formulating standardised terminology for such processes. In The Happy Couple, Katrien Vermeiren of SGS Life Science Services reiterates the benefits of close collaboration between the EDC providers and sponsors  
view
download pdf
Few dispute that EDC provides real-time access to more accurate data, shortening the clinical trial timeframe and automatically generating some level of cost savings. David Laky of eResearchTechnology, Inc, books an Appointment at the eClinic  
view
download pdf
bullet
THERAPEUTICS
As cancer clinical research continues to look for better identification of patients who respond to treatment, in Signature Dish, Marc Buyse of the International Drug Development Institute outlines developments in molecular profiling as a targeted therapy for early breast cancer  
view
download pdf
bullet
Labs & Logistics
With growth expected within the Asia-Pacific and Latin American regions to be around 40 per cent of clinical trial activities by 2011, Jonathan Blamey and Chris Tierney of DHL Healthcare focus on the key areas for logistics providers offering services for clinical trials, in Part of the Process  
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>

Industry Events

Evolution Summit

20-22 July 2020, The Ritz Carlton, Fort Lauderdale, FL

The 22nd Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation-only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement